Antisense oligonucleotide treatment following viral delivery of artificial SOD1-targeting miRNA shows improved efficacy in SOD1-G93A mice.
Overview
and 19 other authors
Kay-Ellen Chicoine1, Paige Cundiff1, Sean Dwyer1, Pete Clarner1, Weike Zeng1, Daniel Ferretti1, Taras Tuczkewycz1, Isabel Isaza1, Melissa Patrovanie1, Collin Mcgladrigan1, Jenhwa Chu1, James P. Morrison2, H. Moore Arnold1, Shen Shen1, Jessica A. Hurt1, Patrick Trapa1, Danielle L. Graham1, Edward D. Plowey1, Shih-Ching Lo1Abstract
The abstract is not reproduced here: the paper's license (CC BY-NC-ND) does not allow it. Read it in the paper, at the publisher or on Europe PMC.
Code
The paper says that its authors' code is available on request: it was not published with the paper, so there is nothing to verify.
The paper's code and data availability statement is in the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none (its code is available on request), so it has no map.
Data
No dataset and no data link were found in the paper.
Code and data availability statement
The paper has a code and data availability statement. Its license (CC BY-NC-ND) does not allow reproducing it here; in short, from what the harvester recognized in it:
- it says that the data are available on request
- it says that the code is available on request
Read it in the paper: doi.org/10.1016/j.omta.2026.201818.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 2, 28 September 2026
- Authors: added Maria I. Zavodszky (0000-0001-7047-6643); Dan Bartlett (0000-0001-8351-2092); Jennifer Sebalusky (0000-0002-9657-875X); Isabel Isaza (0009-0006-1330-2878); Jenhwa Chu (0000-0001-7179-9428); James P. Morrison (0000-0003-3975-1461); H. Moore Arnold (0000-0002-7505-3540); Danielle L. Graham (0009-0009-8598-3088); Edward D. Plowey (0000-0001-9016-4751); Shih-Ching Lo (0000-0002-5187-0730); removed Maria I. Zavodszky; Dan Bartlett; Jennifer Sebalusky; Isabel Isaza; Jenhwa Chu; James P. Morrison; H. Moore Arnold; Danielle L. Graham; Edward D. Plowey; Shih-Ching Lo
Version 1, 27 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 39 authors, 7 keywords, 1 funder, 59 references.
Cite
This paper
Hawley, Z. C., Guise, A. J., Pardo, I. D., Chowdhury, T., Hana, S., Zavodszky, M. I., Engle, L., Wiltberger, K., Bartlett, D., Raitcheva, D., Bommegowda, S., Lee, W.-H., Chen, S. K., Sheehy, A., Driscoll, R., Peterson, M., Sebalusky, J., Hamann, S., Marsh, G., . . . Lo, S.-C. (2026). Antisense oligonucleotide treatment following viral delivery of artificial SOD1-targeting miRNA shows improved efficacy in SOD1-G93A mice. Molecular therapy. Advances, 34(3), 201818. https://
BibTeX
@article{hawley2026antis
author = {Hawley, Zachary C.E. and Guise, Amanda J. and Pardo, Ingrid D. and Chowdhury, Twinkle and Hana, Sam and Zavodszky, Maria I. and Engle, Linda and Wiltberger, Kelly and Bartlett, Dan and Raitcheva, Denitza and Bommegowda, Santhosh and Lee, Wan-Hung and Chen, Shukkwan K. and Sheehy, Adam and Driscoll, Rachelle and Peterson, Michael and Sebalusky, Jennifer and Hamann, Stefan and Marsh, Galina and Doherty, Jessica and Chicoine, Kay-Ellen and Cundiff, Paige and Dwyer, Sean and Clarner, Pete and Zeng, Weike and Ferretti, Daniel and Tuczkewycz, Taras and Isaza, Isabel and Patrovanie, Melissa and Mcgladrigan, Collin and Chu, Jenhwa and Morrison, James P. and Arnold, H. Moore and Shen, Shen and Hurt, Jessica A. and Trapa, Patrick and Graham, Danielle L. and Plowey, Edward D. and Lo, Shih-Ching},
title = {{Antisense oligonucleotide treatment following viral delivery of artificial SOD1-targeting miRNA shows improved efficacy in SOD1-G93A mice}},
journal = {Molecular therapy. Advances},
year = {2026},
month = jul,
volume = {34},
number = {3},
pages = {201818},
publisher = {American Society of Gene \& Cell Therapy},
issn = {3117-387X},
doi = {10.1016/
url = {https://
pmid = {42620667},
pmcid = {PMC13486805}
}
RIS
TY - JOUR
AU - Hawley, Zachary C.E.
AU - Guise, Amanda J.
AU - Pardo, Ingrid D.
AU - Chowdhury, Twinkle
AU - Hana, Sam
AU - Zavodszky, Maria I.
AU - Engle, Linda
AU - Wiltberger, Kelly
AU - Bartlett, Dan
AU - Raitcheva, Denitza
AU - Bommegowda, Santhosh
AU - Lee, Wan-Hung
AU - Chen, Shukkwan K.
AU - Sheehy, Adam
AU - Driscoll, Rachelle
AU - Peterson, Michael
AU - Sebalusky, Jennifer
AU - Hamann, Stefan
AU - Marsh, Galina
AU - Doherty, Jessica
AU - Chicoine, Kay-Ellen
AU - Cundiff, Paige
AU - Dwyer, Sean
AU - Clarner, Pete
AU - Zeng, Weike
AU - Ferretti, Daniel
AU - Tuczkewycz, Taras
AU - Isaza, Isabel
AU - Patrovanie, Melissa
AU - Mcgladrigan, Collin
AU - Chu, Jenhwa
AU - Morrison, James P.
AU - Arnold, H. Moore
AU - Shen, Shen
AU - Hurt, Jessica A.
AU - Trapa, Patrick
AU - Graham, Danielle L.
AU - Plowey, Edward D.
AU - Lo, Shih-Ching
TI - Antisense oligonucleotide treatment following viral delivery of artificial SOD1-targeting miRNA shows improved efficacy in SOD1-G93A mice
T2 - Molecular therapy. Advances
J2 - Mol Ther Adv
PY - 2026
DA - 2026/
VL - 34
IS - 3
SP - 201818
SN - 3117-387X
PB - American Society of Gene & Cell Therapy
DO - 10.1016/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.1016/
"type": "article-journal",
"title": "Antisense oligonucleotide treatment following viral delivery of artificial SOD1-targeting miRNA shows improved efficacy in SOD1-G93A mice",
"container-title": "Molecular therapy. Advances",
"author": [
{
"family": "Hawley",
"given": "Zachary C.E."
},
{
"family": "Guise",
"given": "Amanda J."
},
{
"family": "Pardo",
"given": "Ingrid D."
},
{
"family": "Chowdhury",
"given": "Twinkle"
},
{
"family": "Hana",
"given": "Sam"
},
{
"family": "Zavodszky",
"given": "Maria I."
},
{
"family": "Engle",
"given": "Linda"
},
{
"family": "Wiltberger",
"given": "Kelly"
},
{
"family": "Bartlett",
"given": "Dan"
},
{
"family": "Raitcheva",
"given": "Denitza"
},
{
"family": "Bommegowda",
"given": "Santhosh"
},
{
"family": "Lee",
"given": "Wan-Hung"
},
{
"family": "Chen",
"given": "Shukkwan K."
},
{
"family": "Sheehy",
"given": "Adam"
},
{
"family": "Driscoll",
"given": "Rachelle"
},
{
"family": "Peterson",
"given": "Michael"
},
{
"family": "Sebalusky",
"given": "Jennifer"
},
{
"family": "Hamann",
"given": "Stefan"
},
{
"family": "Marsh",
"given": "Galina"
},
{
"family": "Doherty",
"given": "Jessica"
},
{
"family": "Chicoine",
"given": "Kay-Ellen"
},
{
"family": "Cundiff",
"given": "Paige"
},
{
"family": "Dwyer",
"given": "Sean"
},
{
"family": "Clarner",
"given": "Pete"
},
{
"family": "Zeng",
"given": "Weike"
},
{
"family": "Ferretti",
"given": "Daniel"
},
{
"family": "Tuczkewycz",
"given": "Taras"
},
{
"family": "Isaza",
"given": "Isabel"
},
{
"family": "Patrovanie",
"given": "Melissa"
},
{
"family": "Mcgladrigan",
"given": "Collin"
},
{
"family": "Chu",
"given": "Jenhwa"
},
{
"family": "Morrison",
"given": "James P."
},
{
"family": "Arnold",
"given": "H. Moore"
},
{
"family": "Shen",
"given": "Shen"
},
{
"family": "Hurt",
"given": "Jessica A."
},
{
"family": "Trapa",
"given": "Patrick"
},
{
"family": "Graham",
"given": "Danielle L."
},
{
"family": "Plowey",
"given": "Edward D."
},
{
"family": "Lo",
"given": "Shih-Ching"
}
],
"container-title-short":
"volume": "34",
"issue": "3",
"page": "201818",
"DOI": "10.1016/
"PMID": "42620667",
"PMCID": "PMC13486805",
"ISSN": "3117-387X",
"publisher": "American Society of Gene & Cell Therapy",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
7,
24
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1038/s41434-022-00375-w
- In vivo genome editing using novel AAV-PHP variants rescues motor function deficits and extends survival in a SOD1-ALS mouse model.Journal: Gene therapyIn common: other condition, mouse, 10 references, author Shih-Ching Lo
- [2] doi:10.3390/ijms262311645 [code]
- An AAV-Based Therapy Approach for Neurological Phenotypes of X-Linked Adrenoleukodystrophy.Journal: International journal of molecular sciencesIn common: clinical / translational, 8 references
- [3] doi:10.1172/jci185001
- Cross-species efficacy of AAV-mediated ARSA replacement for metachromatic leukodystrophy.Journal: The Journal of clinical investigationIn common: non-human primate, clinical / translational, other condition, 1 other category, 6 references
- [4] doi:10.1038/s41598-026-38039-z [code]
- Comparison of AAV9-driven motor neuron transduction following different CNS-directed delivery methods in mice.Journal: Scientific reportsIn common: mouse, 6 references
- [5] doi:10.1016/j.omta.2026.201820
- i.c.v. delivery of AAV9-synapsin-promoted caveolin-1 attenuates neuromuscular deficits and neuromuscular degeneration in hSOD1&
lt;sup& gt;G93A& lt;/ sup& gt; mice. Journal: Molecular therapy. AdvancesIn common: other condition, mouse, 6 references - [6] doi:10.1073/pnas.2418024121
- Cis-regulatory elements driving motor neuron-selective viral payload expression within the mammalian spinal cord.Journal: Proceedings of the National Academy of Sciences of the United States of AmericaIn common: mouse, 6 references
- [7] doi:10.1038/s41467-026-73545-8
- Long-term comparative analysis of AAV9-mediated gene replacement therapies for spinal muscular atrophy in mice.Journal: Nature communicationsIn common: other condition, mouse, 5 references
- [8] doi:10.1186/s40478-025-02005-z
- Viral-mediated knockdown of Atxn2 attenuates TDP-43 pathology and muscle dysfunction in the PFN1&
lt;sup& gt;C71G& lt;/ sup& gt; ALS mouse model. Journal: Acta neuropathologica communicationsIn common: other condition, mouse, 6 references - [9] doi:10.1038/s41591-024-03466-w [code]
- In vivo base editing extends lifespan of a humanized mouse model of prion disease.Journal: Nature medicineIn common: other condition, mouse, 5 references
- [10] doi:10.1016/j.ymthe.2025.05.011
- Neuron-targeted gene therapy rescues multiple phenotypes of STXBP1-related disorders in mice and is well tolerated in nonhuman primates.Journal: Molecular therapy : the journal of the American Society of Gene TherapyIn common: non-human primate, other condition, mouse, 4 references
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.
Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
